MAN has participated on advisory boards or has been invited as a speaker by Amylin Pharmaceuticals, AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Diartis Pharmaceuticals Inc., Eli Lilly & Co., GlaxoSmithKline, Hoffmann-La Roche Ltd., Intarcia Therapeutics Inc., Janssen Global Services, MannKind Corp., MSD, Novo Nordisk, Novartis, Sanofi, Takeda, Versartis and Wyeth Research
Its interaction characteristics enable detailed examination of binding behavior, conformational changes, and signaling specificity under well-defined in vitro conditions
Changes in physical activity patterns frequently accompany weight loss treatment
doi:10.1530/REP-14-0435 16
The vote is part of a two-day meeting in which the advisers are voting whether to allow compounding pharmacies to make seven peptides that are used to promote improved health, in some cases by speeding up muscle recovery or improving sleep